These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 16361044)
1. The bulge, booze, and the liver. Adams LA; Angulo P Clin Gastroenterol Hepatol; 2005 Dec; 3(12):1195-7. PubMed ID: 16361044 [No Abstract] [Full Text] [Related]
2. Biphasic effect of alcohol intake on the development of fatty liver disease. Takahashi H; Ono M; Hyogo H; Tsuji C; Kitajima Y; Ono N; Eguchi T; Fujimoto K; Chayama K; Saibara T; Anzai K; Eguchi Y J Gastroenterol; 2015 Nov; 50(11):1114-23. PubMed ID: 25733100 [TBL] [Abstract][Full Text] [Related]
3. Fatty liver: how frequent is it and why? Bedogni G; Bellentani S Ann Hepatol; 2004; 3(2):63-5. PubMed ID: 15257248 [TBL] [Abstract][Full Text] [Related]
5. [Advances in the epidemiological study of fatty liver]. Zhang HJ; Zhuang H; Liu XE Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):630-2. PubMed ID: 15308049 [No Abstract] [Full Text] [Related]
6. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. Caballería L; Pera G; Auladell MA; Torán P; Muñoz L; Miranda D; Alumà A; Casas JD; Sánchez C; Gil D; Aubà J; Tibau A; Canut S; Bernad J; Aizpurua MM Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):24-32. PubMed ID: 19730384 [TBL] [Abstract][Full Text] [Related]
7. Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Ruhl CE; Everhart JE Clin Gastroenterol Hepatol; 2005 Dec; 3(12):1260-8. PubMed ID: 16361053 [TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease, alcohol intake and psoriasis. Bordignon M; Viel G; Peserico A; Alaibac M J Hepatol; 2010 Sep; 53(3):587. PubMed ID: 20561701 [No Abstract] [Full Text] [Related]
9. [Fatty liver]. Geyer O; Yavuz F Med Monatsschr; 1972 Sep; 26(9):411-2. PubMed ID: 5082176 [No Abstract] [Full Text] [Related]
10. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. Kojima S; Watanabe N; Numata M; Ogawa T; Matsuzaki S J Gastroenterol; 2003; 38(10):954-61. PubMed ID: 14614602 [TBL] [Abstract][Full Text] [Related]
11. Ethnicity matters: A Systematic Review and Meta-Analysis of the Non-Linear Relationship Between Alcohol Consumption and Prevalence and Incidence of Hepatic Steatosis. Roerecke M; Nanau R; Rehm J; Neuman M EBioMedicine; 2016 Jun; 8():317-330. PubMed ID: 27428441 [TBL] [Abstract][Full Text] [Related]
12. [A hospital-based case-control study on influencing factors of nonalcoholic fatty liver disease]. Peng XE; Lai ZS; Lu QQ; Lin JY; Lin X Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):535-9. PubMed ID: 19912690 [TBL] [Abstract][Full Text] [Related]
14. Hepatic steatosis in HIV/HCV-coinfected patients: time to reevaluate! McGovern BH Gastroenterology; 2011 Mar; 140(3):772-5. PubMed ID: 21276415 [No Abstract] [Full Text] [Related]
15. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai]. Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689 [TBL] [Abstract][Full Text] [Related]
16. The natural history of nonalcoholic fatty liver disease: insights from children and mice. Ahima RS Gastroenterology; 2008 Dec; 135(6):1860-2. PubMed ID: 19000676 [No Abstract] [Full Text] [Related]
17. Should obesity be recognised as a disease? Wilding JPH; Mooney V; Pile R BMJ; 2019 Jul; 366():l4258. PubMed ID: 31315832 [No Abstract] [Full Text] [Related]